Streetbeat News

Analyst Ratings

PAVM

PAVmed reported Q2 losses of $(0.09) per share, beating the analyst consensus estimate of $(0.19) by 52.63%. However, the company's quarterly sales of $166.00K missed the analyst consensus estimate of $520.00K by 68.08%.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 4:21 am

AAL

GOOG

Ark Investment Management analyst, Sam Korus, sees potential in AI reducing the aviation industry's environmental impact. He cited the example of American Airlines' 70 test flights using a Google-developed AI algorithm, which reduced condensation trails by 54%. Google's algorithm creates forecast maps for contrail formation locations, enabling pilots to avoid them. However, rerouting to avoid contrails resulted in a 2% increase in fuel consumption.

Portfolio Pulse from Anan Ashraf

August 16, 2023 | 3:48 am

DADA

Dada Nexus (NASDAQ:DADA) reported Q2 earnings of $0.00 per share, beating the analyst consensus estimate of $(0.02) by 105 percent. However, the company's quarterly sales of $401.37 million missed the analyst consensus estimate of $418.25 million by 4.04 percent.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 10:03 pm

RDFN

Analysts have provided indifferent to somewhat bearish ratings for Redfin (NASDAQ:RDFN) in the last quarter. The average price target for Redfin is $11.17, which is higher than its current price of $10.01. This average has increased by 25.51% from the previous average price target of $8.90.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 9:00 pm

CYBN

Over the past 3 months, 6 analysts have published their opinion on Cybin (AMEX:CYBN) stock. The company has an average price target of $6.17, a decrease of 5.08% from the previous average price target of $6.50. The majority of the ratings are bullish.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 9:00 pm

CSSE

Chicken Soup for the Soul (NASDAQ:CSSE) has received 4 bullish and 1 indifferent analyst ratings in the last quarter. The average 12-month price target for the company is $3.35, a decrease of 55.33% from the previous average of $7.50.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 9:00 pm

HD

Home Depot Inc (HD) beat earnings estimates for Q2 2023, despite a 2% YoY decrease in revenue to $42.92 billion. The company reaffirmed its guidance for a comparable sales decline between 2% and 5% for full-year 2023 due to broad-based pressure across the business. However, Oppenheimer analyst Brian Nagel believes the company is setting itself up for a recovery in the years ahead, with home improvement trends expected to improve in 2024 and 2025.

Portfolio Pulse from Adam Eckert

August 15, 2023 | 8:33 pm

SGMO

Sangamo Therapeutics (NASDAQ:SGMO) has received 6 bullish ratings in the last quarter, with no bearish or indifferent ratings. The average 12-month price target for the stock, according to 6 analysts, is $6.83, a decrease of 28.85% from the previous average of $9.60.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 8:00 pm

CKPT

Checkpoint Therapeutics (NASDAQ:CKPT) has received 4 analyst ratings in the last quarter, with 3 being bullish and 1 somewhat bullish. The average price target is $27.75, indicating a significant upside from the current price of $2.0. However, this average has decreased by 21.45% from the previous average price target of $35.33.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 8:00 pm

CNTA

Over the past 3 months, 5 analysts have published their opinion on Centessa Pharmaceuticals (NASDAQ:CNTA) stock. The average price target for the stock is $10.0, with a high of $15.00 and a low of $5.00. The average price target has increased by 31.23% over the past month.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 8:00 pm